IQVIA Holdings Inc. (IQV)

NYSE · Healthcare · Diagnostics & Research
$245.82-1.89%As of 2026-11-22 · USD
Last session low $245.25Last session high $252.28
52-week low $154.5052-week high $284.50
Market cap
$40.51B
Sector
Healthcare
P/E (TTM)
29.9x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)34.6In the neutral range (30 to 70)
MACD (12, 26, 9)-3.19Below its signal line (-0.56); histogram -2.63
Bollinger %B (20, 2)-11%Below the lower band (249.62 to 283.66)
SMA 20266.64Price is 7.8% below
SMA 50266.95Price is 7.9% below
SMA 200212.18Price is 15.9% above
ATR (20)3.46% of priceAverage true range per day
52-week position70%In the upper part of the 154.50 to 284.50 range

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Insider filings, 90 daysNo purchases and 1 sale (about $697K).
Latest fiscal yearEnded 2025-12-31: revenue of $16.31B and an operating margin of 14.0%.

More in Diagnostics & Research